Reply to the Editor:  by Hopkins, Richard A.
Stentless valve dehiscence
To the Editor:
With great interest we read the article by
Richard Hopkins and colleagues1 on their
patient who experienced dehiscence of the
preserved noncoronary sinus after subcoro-
nary allograft replacement of the aortic
valve. The authors write that this complica-
tion might not be unique for this method of
allograft implantation and that it could in
fact occur with any type of inclusion tech-
nique, as long as sinuses are retained. They
also suggest that some methods of insertion
of stentless xenograft valves could also be
liable to this complication.
We can confirm that dehiscence of the
stentless xenograft indeed occurs and that
it has a strong predilection for the noncoro-
nary sinus. In 10 of 168 patients, partial
dehiscence was found 4 to 49 months after
subcoronary implantation of a stentless xe-
nograft with preserved noncoronary sinus.2
In contrast to the reported patient, our pa-
tients all received diagnoses relatively early
and all underwent reoperations for present
or feared valve dysfunction. The mecha-
nism, however, seems similar. Supposedly,
proteolytic enzymes from captured blood
cells in the dead space between native and
donor aortas might prevent adequate fusion
of the walls and healing of the anastomosis.
The assumption that this particular prob-
lem is related to the concept of coronary
sinus inclusion seems very likely, and clo-
sure of the dead space might be important
when this particular technique is used.
Paul H. Schoof, MD, PhD
Department of Cardiothoracic Surgery
University Medical Center St Radboud
Nijmegen, The Netherlands
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We appreciate Professor Schoof and his col-
leagues for confirming our observations
concerning the technical predilections for
this complication. We use the stentless xe-
nograft as an aortic root replacement, and
therefore we have no experience with tech-
niques liable to this complication, except
historically with homografts. The 6% inci-
dence in their series with an inclusion tech-
nique retaining 1 or more sinuses is indeed
concerning. We concur that meticulous at-
tention to closure of the dead space between
the native and implanted sinus walls is crit-
ical. When we were using the ‘‘scallop’’
technique, we did use obliterating sutures,
which clearly did not obviate this single oc-
currence. We can only speculate about the
potential usefulness of biologic glues to en-
hance fusion of the walls. In contrast to their
100% reoperation rate, our single case
report was also written to make the point
that in the absence of valve dysfunction,
progressive dehiscence, or the development
of thrombus, conservative management
appears to be safe with antiplatelet therapy
and consistent yearly imaging follow-up.
Richard A. Hopkins, MD
Department of Cardiac Surgery
Children’s Mercy Hospital
Kansas City, Mo
doi:10.1016/j.jtcvs.2008.02.019Management of postintubation
tracheal ruptures
To the Editor:
We read with interest the article by Park and
colleagues,1 who described a new approach
for the intraluminal repair of membranous
tracheal rupture (TR) after emergency intu-
bation. We congratulate them for their result
in an elderly patient in poor condition.
The authors discussed the value of the
different approaches to surgical treatment
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